Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03045783Unknown
Randomised, open-label trial of cefotiam in bacterial infection (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: The incidence of infection after endoscopic treatment at 1 week. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03045783.